Komori
Dexerials (4980) · TargetCited as achieved

Fiscal 2024 targets under the medium-term management plan "Challenge to Evolution"

First written in FY2019. 1 of 5 entries say "Advanced", first in FY2020. Latest entry: FY2024.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019AdvancedFY2020 – FY20222019: 120192020: 120202021: 120212022: 120222023: 020232024: 12024
Same theme, other companies
Setting and achieving performance targets under the medium-term management planA theme 834 companies write about · 78 as a headwind · 1112 as a tailwind

The whole theme swung hardest in 2021: 17 of 79 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 134 companies compared. The sentences above are computed from all 134.Comparing 200 of the theme's 1236 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024Cited as achievedAnnual report

    「The previous medium-term management plan refresh (update) set targets for the fiscal year ending March 2024 of ¥85,200 million in revenue, ¥16,800 million in operating income, ¥23,900 million in EBITDA, approximately 15.0% in ROIC and approximately 15.0% in ROE, but these targets were achieved two years ahead of schedule in the fiscal year ending March 2022.」

    The company reiterated, in explaining the current plan, that the targets for the fiscal year ending March 2024 under the previous medium-term management plan had been achieved two years ahead of schedule, in the fiscal year ending March 2022.
  2. FY2022AchievedAnnual report

    「For the fiscal year ended March 2022, net sales were ¥95.7 billion, operating income was ¥26.6 billion, EBITDA was ¥32.4 billion, ROIC was 22.5% and ROE was 28.5%, achieving two years ahead of schedule the management targets for the fiscal year ending March 2024, the final year of the medium-term management plan refresh (update) announced on 10 May 2021: net sales of ¥85.2 billion, operating income of ¥16.8 billion, EBITDA of ¥23.9 billion, ROIC of approximately 15.0% and ROE of approximately 15.0%.」

    The final-year targets under the medium-term management plan “Challenge to Evolution” were achieved in the fiscal year ending March 2022, two years ahead of the end of the plan period.
  3. FY2021RaisedAnnual report

    「The company revised its earnings plans for the fiscal years ending March 2022 through March 2024, raising the management targets for the final year, the fiscal year ending March 2024, to ¥85,200 million in revenue and ¥16,800 million in operating income. In addition to ROE and EBITDA, ROIC was newly introduced as a management indicator, with targets for the fiscal year ending March 2024 of approximately ¥23,900 million in EBITDA, 15.0% in ROIC and 15.0% in ROE.」

    The final-year targets under the medium-term management plan “Challenge to Evolution” were raised from ¥80,000 million in revenue and ¥10,000 million in operating income to ¥85,200 million and ¥16,800 million, respectively, and ROIC was added as a new indicator.
  4. FY2020AdvancedAnnual report

    「Revenue: ¥58,000 million; ¥57,710 million; down ¥290 million (down 0.5%) Operating income: ¥4,100 million; ¥4,617 million; up ¥517 million (up 12.6%) Net income attributable to owners of the parent: ¥2,450 million; ¥2,734 million; up ¥284 million (up 11.6%) ROE (return on equity): 4.9%; 5.5%; up 0.6 percentage points」

    In the first year of the medium-term management plan “Challenge to Evolution,” revenue fell short of plan, while operating income, net income attributable to owners of the parent and ROE exceeded plan.
  5. FY2019First statedAnnual report

    「For the final year, the fiscal year ending March 2024, we aim to achieve record-high revenue of ¥80,000 million and operating income of ¥10,000 million. (Assumed exchange rate: US$1 = ¥108)」

    The company formulated the five-year medium-term management plan “Challenge to Evolution” covering the fiscal years ending March 2020 through March 2024, setting final-year targets of ¥80,000 million in revenue and ¥10,000 million in operating income.
Moved together

"Continuation of Research and Development Activities" moved the same way as this thread, in the same document, in 3 of its 5 moves.

332222★123456
  1. ★This thread
  2. 1Continuation of Research and Development Activities3×
  3. 2Increase in Shares and Capital Through the Exercise of Stock Acquisition Rights3×
  4. 3New production equipment begins operating at the Tochigi site2×
  5. 4Targeting adjusted ROE of 15% and maintaining a positive equity spread2×
  6. 5Payment of dividends, including a listing commemorative dividend2×
  7. 6Increasing the market share of differentiated technology products and expanding applications for sputtered products2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Dexerials's next results are scheduled for 2026-11-11. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.